Anti-Mü llerian hormone (AMH) is an endocrine marker that can help predict superovulatory responses to treatments administered to cows for embryo production. However, the optimal time of the estrous cycle at which a blood test should be performed for a highly reliable prognosis has not yet been established. Moreover, little is known about the regulation of AMH production. To answer these questions, a study was designed to investigate the regulation of AMH production in cows selected for their high or low ovulatory responses to superovulation. At the granulosa cell level, AMH production was inhibited by follicle-stimulating hormone but enhanced by bone morphogenetic proteins. At the follicular level, the expression of AMH within the follicle was dependent on the stage of follicular development. At the ovarian level, the size of the pool of small antral growing follicles determined ovarian AMH production. At the endocrine level, AMH followed a specific dynamic profile during the estrous cycle, which occurred independently of the follicular waves of terminal follicular development. Cows selected for their high or low responses to superovulation did not differ in the regulation of AMH production, but cows with higher responses had higher plasma AMH concentrations throughout the cycle. The optimal period of the estrous cycle at which to measure AMH concentrations with the aim of selecting the best cows for embryo production was found to be at estrus and after Day 12 of the cycle. Based on this multiscale study, we propose a model that integrates the different regulatory levels of AMH production.
INTRODUCTION
Anti-Mü llerian hormone (AMH), also known as Müllerian inhibiting substance (MIS), is a glycoprotein of 140 kDa belonging to the transforming growth factor beta family that is expressed only in the gonads [1] . AMH has long been known for its developmental effect, causing regression of the Mü llerian ducts in male fetuses [2] , but later studies have shown that AMH exerts inhibitory effects on the development and function of reproductive organs in both sexes [3, 4] . In the ovary, AMH is of key importance: it inhibits the recruitment of primordial follicles into the pool of growing follicles, and it decreases the responsiveness of growing follicles to follicle-stimulating hormone (FSH) [5] [6] [7] [8] . AMH gene expression is restricted to a single cell type, that is, granulosa cells of growing follicles (e.g., cow [9] [10] [11] , sheep [12] , rat [13] [14] [15] , human [16, 17] , mouse [18, 19] , possum [20] , and hen [21] ).
This pattern of expression makes AMH an ideal endocrine marker of the size of the ovarian pool of growing follicles. Presently, AMH is the best endocrine marker of the ovarian follicular reserve in human [22] [23] [24] [25] and in mouse [26] , and we have shown recently that AMH is also a reliable endocrine marker of the population of small antral gonadotropinresponsive follicles in the cow [27] .
Over the past 10 years, attention has been focused on AMH in humans in the context of assisted reproductive technologies (ART). Numerous clinical studies have shown that low plasma AMH concentrations are indicative of ovarian ageing [28] [29] [30] , and, conversely, women with polycystic ovary syndrome have high AMH concentrations [31] [32] [33] [34] . Presently, AMH is the endocrine marker that best predicts the number of oocytes retrieved in response to an ovarian stimulatory treatment in ART [35] [36] [37] [38] [39] [40] . Recent results from our laboratory indicate that AMH is also of interest in the context of multiple ovulation and embryo transfer (MOET) technology, which has a significant role in genetic selection strategies in cattle, because plasma AMH concentrations of individuals before treatment have been found to be characteristic of each animal over a long-term period and predictive of the number of ovulations and embryos produced in response to ovarian superovulatory treatments [27, 41] .
The development of a highly reliable test based on measurements of AMH concentrations in plasma for selecting cows that can produce high numbers of transferable embryos would represent an important advance in MOET technology. In this perspective, the crucial question is the optimal time during the estrous cycle at which a blood test should be performed. However, changes in plasma AMH concentrations during the estrous cycle have not been assessed in the bovine species. The only data available concerning AMH endocrine levels during ovarian cycle have been obtained in the human species, and that data remain controversial. Some studies have shown that no consistent fluctuations in AMH levels occur throughout the menstrual cycle [42] [43] [44] [45] , whereas other studies have reported higher AMH levels in the follicular phase [46, 47] . Moreover, it is worth noting that terminal follicular development follows a distinct pattern in ovaries of cows and women. During the bovine estrous cycle, two to four sequential waves of terminal follicular growth occur, each producing a dominant follicle capable of ovulating, if luteal regression occurs [48] , and variations in AMH concentrations during emergence and regression of the follicular waves remain to be established.
Despite the importance of AMH as an endocrine marker of populations of growing follicles in all studied species, little is known about the regulation of its expression and production. AMH expression has been shown to be highest in granulosa cells of preantral and small antral follicles and to decrease during terminal follicular growth and during atresia (e.g., rat [49] and cow [27] ). Low AMH concentrations have been found in follicular fluid of estrogenic large antral and preovulatory follicles (e.g., human [50] [51] [52] [53] and cow [11, 27] ). The mechanisms that underlie the inverse relationship existing between AMH and CYP19A1 expression in granulosa cells during terminal follicular development are not fully understood. It could be partly explained by the existence of reciprocal inhibiting effects of AMH and estradiol, as AMH has been shown to repress CYP19A1 expression in FSHstimulated rat and porcine granulosa cells [5] , and conversely, estradiol can inhibit AMH expression in the rat ovary [49] . The role of other intrafollicular factors such as growth factors in controlling AMH expression is unknown. Interestingly, AMH expression in granulosa cells has been shown to increase when cells are co-cultured with oocytes of preantral or preovulatory follicles [19] . The oocyte factor responsible for this effect has not yet been identified, but AMH expression was recently shown to be upregulated by bone morphogenetic protein 6 (BMP6), an oocyte-derived factor [54] , in cultured human granulosa/luteal cells [55] , suggesting that factors of the BMP family may participate in the regulation of AMH expression in follicles. Alternatively, it has been proposed that gonadotropins can also regulate AMH expression, but studies have led to contradictory results. In vitro, neither luteinizing hormone (LH) nor FSH have an effect on AMH production by human granulosa cells from normal ovaries, but LH enhances whereas FSH inhibits AMH production by cells from polycystic ovaries [56] , and human chorionic gonadotropin enhances AMH expression in human granulosa/luteal cells [57] . In vivo, administration of FSH to rats inhibits AMH expression in granulosa cells of preantral and small antral follicles [49] ; however, inhibition of gonadotropin secretion by treatment with gonadotropin-releasing hormone antagonist in marmoset has also been shown to decrease AMH expression in preantral follicles [58] . From these results, further studies are clearly needed to establish the role of gonadotropins and BMP in regulating AMH expression and AMH secretion by granulosa cells.
With the aim of understanding the mechanisms that regulate AMH production in the cow, a multiscale study was designed at the endocrine, ovarian, follicular, and granulosa cell levels. Experiments aimed 1) to establish the relationships existing between changes in plasma AMH concentrations during a natural estrous cycle and the dynamics of ovarian follicular waves; 2) to further characterize the follicular populations producing AMH in cow ovaries; and 3) to study the regulation of AMH expression and AMH secretion by FSH and BMP in granulosa cells. The importance of these regulations on the practical implementation of a reliable test based on measurements of plasma AMH concentrations for selecting the best cows for embryo production was assessed by comparing cows with high responses versus those with low responses to ovarian superovulatory treatment.
MATERIALS AND METHODS

Animals and Experimental Design
Forty-two Prim' Holstein dairy cows, 4-7 years old, were used for experiments conducted during 2008 and 2009. Animals were housed in free stalls and provided feed and water ad libitum. All procedures were approved by agricultural and scientific research agencies (approval number C37-175-2) and conducted in accordance with the guidelines for the Care and Use of Agricultural Animals in Agricultural Research in Teaching. The experimental protocol aimed to compare AMH production in two groups of cows that differed in their ovulatory response to an ovarian stimulation test. In this perspective, cows were subjected first to an ovarian stimulation test, which allowed us to select animals with a high or low ovulatory response. After a resting period of at least 2-months, the cows from each group were either studied throughout a natural estrous cycle or used for ovarian analyses or granulosa cell cultures.
Ovarian Stimulation Test
The 42 tested cows received subcutaneous progesterone implants (Crestar; Intervet, Angers, France) over 10 days. Eight days after implant insertion, cows were superovulated with a total of 32 mg FSH (Stimufol; Merial, Lyon, France), which was given as twice-daily injections over 4 days on a decreasing dose schedule [59] . An intramuscular injection of prostaglandin (PG) F 2a , 22.5 mg (Prosolvin; Intervet), was administered at the time of the fifth FSH injection to induce luteolysis, and progesterone implants were removed at the time of the sixth FSH injection. The number of ovulations induced by the superovulatory treatment was assessed 7 days after estrus by counting the corpora lutea (CL) present on the ovaries by ultrasonography scanning (US) with a transrectal probe, model LV 513 (6.0/8.0-MHz transducer; MyLab30; Esaote). Then, the cows with between 10 and 15 ovulations were discarded from the experiment, and the 22 remaining cows were assigned to two groups, according to their high (H; number of CL .15, n ¼ 10) or low (L; number of CL ,10, n ¼ 12) ovulatory response. All selected animals were not available at the same time, so that different subsets of these cows were used for the subsequent in vivo and in vitro experiments that were performed.
Estrous Cycle and Follicular Wave Monitoring
From the time natural estrous behavior occurred (Estrus 1, Day 1 of the estrous cycle) to the next estrus (Estrus 2), cows underwent ovarian US three times weekly to follow follicular waves (FW). For each follicle, the antrum size was estimated by measurement of its diameter when the antral cavity appeared to be at its maximal size on the video images. Transrectal probe LV 513 made it possible to measure the antrum diameter with an accuracy of 60.1 mm. All follicles with an antrum larger than 3 mm in diameter (US size) were counted and measured. The locations of each follicle larger than 5 mm in diameter were drawn on an ovarian map, and individual follicular growth curves were constructed. Two periods were delimited for intraindividual comparisons: the First FW period, which ran from the emergence of the first group of growing follicles .5 mm in diameter after ovulation until the dominant follicle reached its maximal size, and the Last FW, which led to ovulation. Blood samples were recovered daily from cows in a heparinized tube and centrifuged at 3200 3 g for 10 min at 48C to enable recovery of plasma, which was stored at À208C until estradiol-17b, progesterone, and AMH assays were carried out.
Signal Processing of Hormonal and Follicular Time Series
Signal processing was performed with Scilab-Scicos academic software (http://www.scilab.org/ and http://www.scicos.org/). Hormonal and follicular series were analyzed in two ways. First, we compared average values over the First and Last FWs; and second, we assessed the slow dynamics of AMH during the cycle and the temporal relationships among AMH, dominant follicle diameter, and estradiol-17b during its ascending phases in the First and Last FWs. To recover the synchronization between the hormonal and follicular series, which were measured with different sampling frequencies, follicle data were resampled by interpolation with a third-order spline function to get equally spaced time series with the same daily sampling time as hormonal data. An estimation of AMH slow dynamics was made through a low-pass filter with a finite impulse response, which kept only the slow tendency of the series below the given cut-off frequency corresponding to a 10-day period [60] . Then, we applied cross-correlation analysis between hormonal and follicular series. This method estimates the correlation between one time series at time t and another time series at any time, t 6 x, lags [61] . Cross-correlation coefficients were computed using a Matlab xcorr function (MathWorks, Inc.) after subtracting the means from the time series. Coefficients of the unlagged data stand at the midpoint (Lag 0). An average estimate of the correlation over all cows was derived after checking data homogeneity (using a nonsignificant Z test and the Jarque-Bera test) [62] . A 5% level of probability was considered significant (Bravais-Pearson r critical values).
Ovaries, Granulosa Cell, and Follicular Fluid Collection
Cows were treated with two intramuscular injections of PG, 15 mg, spaced 11 days apart, to induce luteolysis and synchronize the occurrence of estrus. The occurrence of ovulation was checked by ovarian US 5 days after each PG injection. Animals were slaughtered 6 days after the second PG injection, i.e., after emergence of the First FW of the synchronized cycle but before development of a dominant follicle [11, 63] . At slaughter, blood samples were recovered, and plasma samples were stored at À208C. For each cow, an ovarian fragment of about 2 cm 3 , devoid of visible follicles larger than 4 mm in diameter, was fixed in Bouin fixative for AMH immunohistochemistry analysis. For the remaining ovarian tissues, all follicles between 3 and 10 mm in diameter were carefully dissected with scissors and dissecting forceps and counted and measured. Follicle size was estimated by measurement of two perpendicular diameters of each follicle with a millimeter scale. Follicular fluids from large follicles (.5 mm) were recovered individually and stored at À208C until AMH assay was performed. For smaller follicles (3-5 mm), due to their small size, the follicular fluids recovered from each cow were pooled. Granulosa cells were also recovered from follicles of both ovaries of each cow as previously described [64] , and granulosa cell suspensions were pooled according to the size (3-5 mm or 5-10 mm) of follicles.
Granulosa Cell Cultures
For AMH production studies, granulosa cells recovered from 3-5 mm and 5-10 mm follicles were cultured separately in McCoy 5A medium (Sigma, L'Isle d'Abeau Chesnes, France) without serum, according to a previously described method [65] . Cells were seeded at 10 5 viable cells/well in 96-well plates and cultured at 378C with 5% CO 2 with or without FSH (5 and 50 ng/ml; purified ovine FSH-19, FSH activity ¼ 963 the activity of ovine FSH-S1, 2351 IU/mg, lot no. AFP-4117A, National Institute of Diabetes and Digestive and Kidney Diseases, National Hormone Pituitary Program, Bethesda, MD), BMP4, and BMP6 (50 ng/ml each; R&D Systems, Lille, France). BMP4 and BMP6 were chosen for this study because they are known to activate the SMAD1/5/8 signaling pathway, but they are, respectively, expressed by theca cells and oocytes [54, 66, 67] . Cells were incubated for 96 h, and culture media were changed at 48 h. Each condition was tested in triplicate in each granulosa cell culture. At the end of the culture period, culture medium was removed and stored at À208C until AMH assays were carried out. Cells were detached with Accutase (Sigma, L'Isle d'Abeau Chesnes, France), and cells in an aliquot of each suspension were counted using a hemocytometer under a phase-contrast microscope to estimate the total number of cells per well.
For AMH mRNA expression analysis, granulosa cells recovered from 3-5 mm and 5-10 mm follicles were seeded at 2 3 10 6 viable cells/well in 6-well plates and cultured at 378C with 5% CO 2 in McCoy 5A medium with 3% fetal bovine serum for 48 h. Then, cells were washed with phosphate-buffered saline (PBS) and treated with or without FSH, BMP4, and BMP6 (each, 50 ng/ ml) for an additional 48 h under serum-free conditions. Each condition was tested in duplicate for each granulosa cell culture. At the end of the culture period, granulosa cells were detached with Accutase, recovered in sterile Eppendorf tubes, washed by centrifugation, and stored at À808C until RNA extraction.
Hormonal Assays
Estradiol-17b was assayed in plasma samples recovered daily during the estrous cycle. A total of 600 ll of plasma was extracted with 3 ml of ethyl acetate-cyclohexane (v/v); dried extracts containing steroids were recovered in 300 ll of PBS and then measured by radioimmunoassay. The percentages of steroid recovery varied between 88% and 92%. Estradiol-17b was then measured with an estradiol-2 radioimmunoassay kit following the manufacturer specification (Diasorin SA, Antony, France). The antiserum of the kit crossreacted slightly with estrone (0.6%) and estriol (0.6%) and less with other steroids (0.1%). The limit of detection of the assay was 0.08 pg per tube, and the intra-assay coefficient of variation was lower than 10%.
Progesterone was assayed in plasma samples recovered daily during the estrous cycle by ELISA as previously described [68] . Progesterone was measured on 10 ll of undiluted plasma. The antiserum cross-reacted with 5a-pregnan-3 and 20-dione (40%); slightly with 17-hydroxyprogesterone (1.6%), pregnenolone (0.2%), corticosterone (0.3%), and androstenedione (0.55%); and less with other steroids (,0.1%). The limit of detection of the assay was 4 pg per tube, and the intra-assay coefficient of variation was lower than 10%.
AMH was measured with an Active MIS/AMH ELISA kit (Beckman Coulter France, Roissy CDG, France), which was previously validated for bovine follicular fluid [11] and plasma [27, 41] . AMH was measured on 50 ll of undiluted plasma or culture medium and 20 ll of follicular fluid diluted 1:5000 for small follicles and 1:100 for large follicles. The limit of detection of the assay was found to be 1 pg per well. The intra-assay coefficients of variation were 11.8% and 3.6% for quality control plasma samples containing 33 and 125 pg/ml AMH, respectively. AMH was undetectable in bovine serum from castrated animals.
Histological Analysis and AMH Immunohistochemistry
Ovarian fragments were embedded in paraffin and serially sectioned at a thickness of 10 lm with a microtome. Histological analysis and AMH immunohistochemistry analysis were performed on adjacent sections. For histological analysis, the diameter and degree of atresia of each follicle were estimated according to classic histological criteria, using sections stained with hematoxylin. Follicles were judged normal when frequent mitosis and no pycnosis were found in granulosa cells. Follicles were judged atretic when there was no mitosis and the presence of pycnoses in granulosa cells. Follicular diameters were measured using a microscope (Zeiss, Germany ) linked to a personal computer-based image analyzer (Visilog version 6.5; Noesis, Velizy, France) in sections where follicles were present at their maximal size. Afterward, follicles were classified according to their size: ,0.2 mm; 0.2-0.5 mm; 0.5-1.5 mm; and 1.5-3.5 mm.
For AMH detection by immunohistochemistry, sections were deparaffinized in toluene, rehydrated, and incubated in antigen unmasking solution (Vector Laboratories, Burlingame, VT) for 4 min in a microwave and then left for 2 h at room temperature. Sections were washed three times in washing solution (PBS, saponin 0.1%) and then treated with 0.3% H 2 O 2 for 30 min at 48C in darkness, to remove endogenous peroxidase. After sections were washed three times, they were incubated with mouse monoclonal anti-AMH antibody raised against bovine AMH (antibody 168 [69] diluted 1:2000 in PBS, saponin 0.1%, BSA 0.1%) in a humidified chamber overnight at 48C. Sections were washed three times and then incubated with donkey anti-mouse peroxidaseconjugated secondary antibody (Jackson Immunoresearch Laboratories, West Grove, PA) diluted 1:800 in PBS, saponin 0.1%, and BSA 0.1% at room temperature for 4 h.
Immunostaining was developed by incubating sections in 50 mM Tris-HCl (pH 7.8) containing 0.4 mg/ml 3,3 0 -diaminobenzidine tetrahydrochloride dehydrate (Sigma, L'Isle d'Abeau Chesnes, France) and 0.012% H 2 O 2 for 10 min at room temperature. Negative control sections involved omitting the primary antibody from the procedure.
Quantification of immunostaining was performed by densitometric analysis using the microscope-linked personal computer-based image analyzer, VISILOG 6.5. Each section was analyzed with a 1003 objective. Quantitative analysis was performed on follicles between 0.1 and 3.5 mm in diameter. For each follicle, the mean optical density of staining (expressed in arbitrary units) was estimated from microscopy measurements of 49-lm 2 fields chosen at random in the external granulosa layer (close to the theca), in the internal granulosa layer (close to the antrum), and in cumulus cells. Fields were carefully chosen that were completely occupied by granulosa cells; fields containing part of an antral cavity were not analyzed. Specific immunostaining was obtained after subtraction of the background staining level (nonspecific staining), as measured with ovarian stroma in each analyzed section.
Reverse Transcription and Quantitative PCR
Cultured granulosa cell samples were analyzed for AMH mRNA content. Total RNA was extracted from granulosa cell samples with a Nucleospin RNA II kit (Macherey-Nagel, Hoerdt, France) according to the protocol of the manufacturer. Total RNA was reverse-transcribed using 1 lg of RNA, and realtime quantitative PCR reactions were run using SYBR Green Supermix (BioRad, Marnes la coquette, France) on an iCycler iQ multicolor detection system (Bio-Rad, Marnes la Coquette, France) as previously described [11] . The specific primer sequences used for AMH amplification were forward 5 0 -GTGGTGCTGCTGCTAAAGATG-3 0 and reverse 5 0 -TCGGACAGGCTGAT GAGGAG-3 0 ; and for the reference RPL19 gene were forward 5 0 -AATGC CAATGCCAACTC-3 0 and reverse 5 0 -CCCTTTCGCTACCTATACC-3 0 . For each primer pair, efficiency curves were generated as described previously [11] . Amplification efficiency, E, of AMH (E AMH ) ¼ 1.88 and E RPL19 ¼ 1.95. For quantification analysis, the cycle threshold (C t ) of the AMH target gene was compared with that of the RPL19 internal reference gene encoding a ubiquitous ribosomal protein according to the ratio
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Statistical Analysis
All data are presented as means 6 SEM. To compare repeated measures in a group, paired tests were applied: the parametric paired t-test (two repeats) or the one-way repeated ANOVA (several repeats) in case of homogeneity of variances and normality of populations, the nonparametric Wilcoxon matched pairs test or repeated measures ANOVA on ranks otherwise. For betweengroup comparisons, unpaired tests were applied: the parametric unpaired t-test (two groups) or the one-way ANOVA (several groups) in the case of homogeneity of variances and normality of populations, the nonparametric Mann-Whitney rank sum test or the Kruskal-Wallis test otherwise. A Spearman rank order test was used to assess correlations among global averaged variables. For all analyses, a 5% level of probability at least was required.
RESULTS
AMH Endocrine Levels During Estrous Cycle
Endocrine and follicular parameters were compared throughout a natural estrous cycle between cows with either a high (H group) or a low (L group) ovulatory response to the ovarian stimulation test performed to select cows before they entered the experimental protocol. In the selected experimental cows, the numbers of ovulations observed in response to this test was about threefold higher in the H group (21.5 6 0.45, n ¼ 6) than in the L group (6.8 6 0.97, n ¼ 5). During the estrous cycle of these cows, the average concentrations of estradiol17b and progesterone in plasma did not differ between groups, but the average AMH concentration was higher (P , 0.01) in the H group (94.8 6 11.2 pg/ml) than in the L group (40.7 6 14.8 pg/ml) of cows. When the cows of the two groups were considered together, the average AMH concentration was strongly correlated with the average number of follicles with diameters between 3 and 5 mm, as detected by ovarian US during the cycle (r ¼ 0.71; P , 0.002; n ¼ 11).
Further analysis was aimed at comparing endocrine and follicular parameters from the two groups of cows during the different waves of terminal follicular development. As the lengths of the studied estrous cycles varied from 20 to 32 days between cows, the number of FWs that occurred during the cycle varied from 2 to 4 but did not vary between groups (H group, 2.7 6 0.33 FW; L group, 2.8 6 0.44 FW). Consequently, the First FW, corresponding to the emergence of the first group of growing follicles .5 mm in diameter after ovulation, and the Last FW, leading to the next ovulation, could only be compared in all the studied cows ( Table 1 ). The lengths of FWs and the number of follicles .5 mm in diameter (US size) per wave were similar between the First and the Last FW and did not differ between groups. However, AMH concentration was higher in the H group than in the L group during both the First and the Last FW. The number of 3-5 mm follicles (US size) was also higher in the H group during the Last FW, and a similar tendency was observed during the First FW (P ¼ 0.1). In the H group of cows, all AMH and estradiol- 17b concentrations and numbers of 3-5 mm follicles were higher during the Last FW than during the First FW. The differences observed between the First and Last FWs led us to focus on the dynamics of AMH changes during the cycle (Fig. 1A) . A profile in two steps was observed for all cows, consisting of a diminution in AMH concentrations after estrus (Day 1), followed by a secondary augmentation, leading to similar values at Estrus 2 and Estrus 1 for each group (Table  2) . This profile was observed regardless of the number of FW per cycle and was independent of their occurrence. Due to the lower averaged values, this pattern was less obvious in the L group. Nevertheless, a repeated-measures analysis performed on the three extreme AMH values, normalized to the mean AMH level in each cow, revealed highly significant differences between AMH values for the two groups (Table 2 ). Neither the percentage of AMH diminution (H group, 34.4% 6 7.1%; L group, 52.1% 6 11.3%) nor the day of occurrence of minimal AMH concentrations (H group, Day 5.6 6 1.1; L group, Day 7.6 6 0.4) differed between groups. These changes in AMH concentrations during the estrous cycle were not associated with concomitant changes in the numbers of follicles detected by ovarian US (Table 2) . When the cows of the two groups were considered together, the Spearman r coefficient of correlation between the daily AMH concentrations and the number of ovulations observed in response to the ovarian stimulation test also exhibited a profile in two steps, with a decrease until the lowest and nonsignificant values around Days 4-8 and an increase thereafter (Fig. 1B) . Finally, the highest (r . 0.70) and most significant (P , 0.02) correlations stood at estrus and after Day 12.
In a further analysis, we investigated the temporal relationships between the endocrine parameters and the growth of the dominant follicle. The dynamic patterns of the hormonal time series and the follicular growth curves were similar in Day of the occurrence of minimal AMH concentrations for each cow. z Ratio AMH:mean AMH. a,b At each time of the cycle, different superscript letters indicate significant differences between the two groups (P , 0.05). ** Asterisks (** P , 0.01) indicate significant differences with AMH at estrus 1 and at estrus 2 within each group.
FIG. 2. Synchronized hormonal and folli-
cle time series of a representative example of H and L groups of cows during a natural estrous cycle. From top to bottom, progesterone, estradiol-17b, raw and low-pass filtered AMH, and daily resampled FW are shown. Shaded areas correspond to increasing estradiol-17b phases of the First and Last FWs. The low-pass-filtered AMH, keeping only its long-term variations, points out the slow dynamics in two steps during the cycle and the correlations with estradiol-17b (negative during the First FW, positive during the Last FW).
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both groups, as illustrated in Figure 2 . During the First FW, estradiol-17b concentrations increased progressively before decreasing abruptly when progesterone concentrations in plasma exceeded 2 ng/ml. The low-pass filtering of AMH time series enabled us to assess temporal relationships between time series, removing AMH daily variability. Then, crosscorrelation coefficients were estimated between estradiol-17b concentrations and the dominant follicle diameter or AMH concentrations during the increasing estradiol-17b phase of the First and Last FWs for each cow (Fig. 2) . As shown in Figure   3 , the mean highest cross-correlation coefficients between estradiol-17b and the dominant follicle diameter in the two FWs were observed at Lag 0 (a perfect temporal coincidence between data), and they were positive (First FW, r ¼ 0.90, P , 0.01; Last FW, r ¼ 0.97, P , 0.0001 for 9 cows; the follicle diameters of the two remaining cows were stable or slightly decreased). In contrast, the mean cross-correlation coefficients between AMH and estradiol-17b were negative during the First FW and positive during the Last FW, with the same high significance (First FW, r ¼ À0.94, P , 0.001; Last FW, r ¼ The number of studied follicles is indicated in parentheses at the top of the bars. A) Immunostaining intensity of external and internal granulosa cells in different size classes of healthy follicles. For 1.5-3.5 mm follicles, different letters indicate significant differences between external and internal granulosa cells (P , 0.05), and asterisks (***, P , 0.001) indicate significant differences compared to external granulosa cells of the other size classes. B) Immunostaining intensity in internal and external granulosa cells and in cumulus of healthy and atretic 1.5-3.5 mm follicles. In external and internal granulosa cells, asterisks (**, P , 0.01; ***, P , 0.001) indicate significant differences between healthy and atretic follicles. 566 0.94, P , 0.001), revealing an inverse tendency in the evolution of AMH plasma levels between the two FWs.
Follicular AMH Levels
Follicular populations producing AMH were characterized in the H and L groups of cows. The number of follicles 3-5 mm in diameter present in ovaries at slaughter was higher in the H group, but there was no difference in the number of follicles .5 mm between groups (Fig. 4A) . Intrafollicular AMH concentrations were not different between groups in all follicular size classes, but they decreased when follicular size increased from 3 to 10 mm in diameter (Fig. 4B) . In a few samples of follicular fluids recovered from small antral follicles, intrafollicular AMH concentrations were found to be similar in follicles of 1-3 mm and 3-5 mm (536.5 6 126.9 pg/ml vs. 605.2 6 95.8 pg/ml, respectively; n ¼ 4, not significant).
Populations of preantral and small antral follicles from the H and L groups of cows were analyzed for AMH immunostaining. In both groups, AMH was localized in granulosa cells of preantral follicles (Fig. 5, A and B) , antral follicles (Fig. 5, C , D, and F), and the cumulus oophorus (Fig. 5E) . No difference was found in AMH immunostaining intensity between groups (data not shown), so that data obtained from follicles of the H and L groups were pooled for further analyses. In healthy follicles ,1.5 mm in diameter, AMH immunostaining intensity was similar in granulosa cells close to the theca (external granulosa) and in granulosa cells close to the antrum (internal granulosa). However, in follicles 1.5-3.5 mm, AMH immunostaining was present as a gradient (Fig. 5D) , with the intensity being higher in external granulosa. AMH immunostaining intensity in external granulosa was clearly higher in follicles 1.5-3.5 mm than in smaller follicles (Fig. 6A) . AMH immunostaining intensity decreased significantly with atresia in both external and internal granulosa for follicles of 1.5-3.5 mm, whereas AMH immunostaining intensity in the cumulus oophorus did not change (Figs. 5F and 6B).
Regulation of AMH Production by FSH and BMP in Granulosa Cells
Regulation of AMH secretion and AMH mRNA expression by FSH, BMP4, and BMP6 was studied in granulosa cells from the H and L groups of cows. No differences were found in AMH secretion and AMH expression between groups (data not shown), so that data obtained from granulosa cells of the H and L groups were pooled for further analyses.
FSH inhibited AMH secretion by granulosa cells from 3-5 mm follicles (Fig. 7A ) and reversed BMP-enhanced secretion by granulosa cells from 5-10 mm follicles (Fig. 7B) . FSH also decreased AMH mRNA levels in granulosa cells from 5-10 mm follicles (Fig. 8B) . Conversely, BMP4 and BMP6 enhanced AMH secretion by granulosa cells from 5-10 mm follicles (Fig. 7B) and increased AMH mRNA levels in granulosa cells from 3-5 mm follicles (Fig. 8A ) and 5-10 mm follicles (Fig. 8B) . Altogether, these results indicate the existence of an antagonism between FSH and BMP in the regulation of AMH expression and production by granulosa cells.
DISCUSSION
In this multiscale study, the regulation of AMH production in the cow was investigated at the cellular, follicular, ovarian, and endocrine levels concomitantly for the first time. The main results have shown that 1) at the granulosa cell level, FSH and BMP regulate AMH production in an opposite way; 2) at the follicular level, the expression of AMH within the follicle is dependent on the stage of follicular development; 3) at the ovarian level, the size of the follicular pool of small antral growing follicles determines ovarian AMH production; and 4) at the endocrine level, AMH follows a specific profile during the estrous cycle, which occurs independently of the follicular waves of terminal follicular development. Moreover, this study made it possible to define the optimal period in the estrous cycle during which to measure plasma AMH concentrations for the purpose of selecting cows able to produce high numbers of transferable embryos.
At the granulosa cell level, AMH production was inhibited by FSH but was enhanced by BMP in vitro. The observed effects on AMH secretion and AMH expression were quite similar between cultured granulosa cells recovered from two size classes of antral follicles, despite a higher responsiveness from 3-5 mm follicles and 5-10 mm follicles to FSH and BMP, respectively. Opposite effects of BMP and FSH on AMH secretion were clearly observed in granulosa cells from 5-10 mm follicles. At the molecular level, these results suggest the existence of opposite actions of FSH-stimulated cAMP and BMP-stimulated SMAD1/5/8 signaling pathways on AMH expression, as shown previously for the STAR and CYP11A1 target genes and others [70] . Up to now, the molecular mechanisms regulating AMH expression have been investigated only in males [71] [72] [73] . The mechanisms by which FSH and BMP regulate AMH expression in an opposite way in granulosa cells remain to be explored. The effects of other factors of the BMP family, such as the oocyte-derived factors BMP15 or GDF9, the latter being known to activate the SMAD2/3 pathway [74] , should also be established.
AMH expression was observed in granulosa cells of growing preantral and antral follicles but not primordial ones, in agreement with results of previous studies [12, 20, 25, 49] . Cumulus cells and the outer layers of granulosa cells close to the theca were shown to be preferred zones of high AMH expression in healthy antral follicles larger than 1.5 mm in diameter. Moreover, in atretic follicles, AMH expression was strongly diminished, except in the cumulus cells surrounding the oocyte. In the mouse, the oocyte has been shown to enhance AMH mRNA expression in co-cultured granulosa [19] , but the factor responsible for this effect has not been identified. Interestingly, the oocyte can also prevent cumulus cell apoptosis by maintaining a morphogenic paracrine gradient of BMP in mouse follicles [75] . From our results, BMP6 and BMP4, known to be expressed in oocyte and theca cells, respectively [54, 66, 67] , enhanced AMH expression in granulosa cells. This effect was not the only consequence of the antiapoptotic effect of BMP, as it was observed in viable granulosa cells after culture. Altogether, these results strongly suggest that BMP, of oocyte and thecal origin, support AMH expression in growing follicles and participate in its regionalization during follicular development, but a possible paracrine role of other factors must also be considered.
The healthy small antral follicles with diameters between 1 and 5 mm contained the highest AMH concentrations in follicular fluid and exhibited the highest AMH immunostaining in their granulosa outer cell layers. Follicles between 1 and 5 mm in diameter are at their largest at the basal follicular growth stage in the cow; beyond this size, follicles are known to enter terminal growth stage, and their development occurs through successive follicular waves and is highly dependent on gonadotropins [48, 63] . Our results suggest that these follicles produce the highest amounts of AMH, but they do not exclude the possibility of important contributions from other follicles, particularly the largest preantral ones, to AMH levels in plasma. The selection of cows with high and low responses to an ovarian stimulation test performed several months previously resulted in sorting animals with high and low numbers of 3-5 mm follicles on ovaries and high and low plasma AMH FIG. 9. Multiscale regulation of AMH production. A working model of the regulation of AMH production is shown that integrates the cellular, follicular, ovarian, and endocrine levels. AMH expression (red) is the highest in the outer granulosa cells and in the cumulus cells of small antral 1-5 mm follicles, i.e., the largest follicles of the basal follicular development stage in the cow. Intrafollicular factors such as BMP, of theca cell and oocyte origin, can enhance AMH expression in granulosa cells, whereas FSH, acting as an endocrine, exerts an inhibiting action. AMH endocrine levels decrease during the days following estrus, likely in response to the actions of preovulatory and periovulatory FSH surges on the population of high AMH-secreting follicles of the basal follicular development stage. X, hypothetical factor of thecal origin, which might also enhance AMH expression in granulosa. 568 concentrations, respectively. Interestingly, AMH expression in granulosa cells during follicular development in vivo and in response to FSH and BMP in vitro were similar in the two groups of cows. Altogether, these results support our earlier investigation indicating that the population of the largest follicles of the basal follicular growth stage is steady with time and confirm that the size of this population determines the intrinsic AMH endocrine levels of every cow [27] .
Despite the existence of important differences between cows in AMH mean endocrine levels, estrous cycle length, and numbers of follicular waves per cycle, the profile of AMH changes during a natural estrous cycle was quite similar for all the studied cows. It consisted of a rapid decrease in AMH concentrations after estrus, reaching minimal values between Days 4 and 8 of the cycle, followed by a slow increase until the next estrus. Some studies in women have also reported higher AMH levels in the follicular phase of the menstrual cycle [46, 47] . From our results with the cow, AMH was shown to follow an inverse pattern during the first and last follicular wave of the cycle, as it was first negatively and then positively correlated with estradiol-17b endocrine levels during the first and last follicular wave, respectively. In contrast, during both follicular waves, the development of a dominant follicle was paralleled by an increase in estradiol-17b endocrine level, as expected, confirming that estradiol-17b is a reliable endocrine marker of terminal follicular development [48] . Altogether, these results strongly suggest that AMH endocrine levels are independent of the occurrence of waves of terminal follicular development in cow ovaries.
Our results show that FSH could modulate AMH endocrine levels significantly. In vitro, FSH, acting at 5 and 50 ng/ml, strongly inhibited AMH secretion by granulosa cells from 3-5 mm follicles. In vivo, the occurrence of two successive FSH surges in the preovulatory and periovulatory periods, each with a magnitude higher than 10 ng/ml, is well established in the cow [76] . The preovulatory FSH peak occurs at estrus concomitantly with the preovulatory LH peak. The dominant follicle responds to the LH peak with a rapid decline of estradiol-17b and inhibin A production, which in turn leads to the second rise in FSH concentration that reaches its maximum after approximately 24 h around the time of ovulation [77, 78] . This periovulatory FSH peak returns to basal levels approximately 24-48 h later due to estradiol-17b and inhibin A production of the largest follicles [63, 79, 80] . The sharp decrease in AMH concentrations occurring in plasma of all cows during the 4 days following estrus was not associated with concomitant changes in the numbers of follicles detected by ovarian US, but it could result from the inhibiting action of FSH upon AMH production by granulosa cells of the AMHsecreting follicles in the basal follicular growth stage. The possibility of direct or indirect effects of other pituitary regulators, such as LH, growth hormone (GH), or prolactin, on AMH production should also be investigated, as they produce a concomitant endocrine surge at the time of the preovulatory but not periovulatory FSH surge [81, 82] .
Establishment of the dynamic profile of AMH levels in cows has important practical consequences for the development of a highly reliable test based on the measurement of plasma AMH concentrations for selecting cows able to produce high numbers of transferable embryos. Results of this study give new information about the optimal period of the estrous cycle during which a blood test should be performed. The optimal days should correspond to the period of the cycle with the highest differences in AMH concentrations between groups and the highest correlations of these concentrations with the numbers of CL observed in response to the ovarian stimulation test. Conversely, the period of time that would not allow us to distinguish between groups should be considered unfavorable. In the studied cows, the highest correlations between the number of ovulations observed after an ovarian stimulation test and AMH endocrine levels during a natural estrous cycle stood at estrus and after Day 12 of the cycle. In contrast, correlations were not significant between Days 4 and 8 of the cycle, corresponding to a period of low AMH levels in all cows. This result can be explained by a reduction of the difference between groups of cows when AMH concentrations were low combined with the lower precision of the assay for low AMH concentrations.
This multiscale study of AMH production at cellular, follicular, ovarian, and endocrine levels allows us to propose a model that integrates the different regulatory levels (Fig. 9 ). In this model, the cellular unit producing AMH is the granulosa cell of growing follicles. The AMH expression level of each granulosa cell depends on the stage of follicular development but also, importantly, on its location inside the follicle. Among growing follicles, the population of largest follicles of the basal follicular development stage constitutes the pool of high AMHsecreting and gonadotropin-responsive follicles. The size of this pool, i.e., the number of healthy follicles at this stage, varies between individuals but is quite steady within the animal over the long term and represents an intrinsic characteristic of each animal. The size of the follicular pool of AMH-secreting follicles and their responsiveness to intrafollicular and endocrine regulating factors such as BMP and FSH, respectively, could both account for AMH endocrine levels. At each estrous cycle, the preovulatory and periovulatory FSH surges would inhibit AMH production by granulosa cells during the days following estrus, leading to a decrease in AMH endocrine levels. As a consequence, the optimal time for a blood test for estimating the size of the pool of gonadotropin-responsive follicles through measurement of AMH endocrine levels should take into account this dynamic profile for each cow to be tested.
